Rwanda Food and Drugs Authority

What Rwanda Food and Drugs Authority does

Rwanda Food and Drugs Authority (Rwanda FDA) is the Government of Rwanda's national regulatory authority responsible for protecting public health through oversight of human and veterinary medicines, vaccines and biological products, processed foods, poisons, medicated cosmetics, medical devices, household chemical substances, and tobacco products. It operates under the Ministry of Health and holds exclusive statutory jurisdiction over product registration, premise licensing, import/export authorization, GMP/GDP compliance verification, post-market surveillance, and pharmacovigilance within Rwanda. The authority regulates pharmaceutical manufacturers and distributors, food processors, cosmetics and household chemical manufacturers, medical device companies, retail pharmacies and wholesale distributors, hospitals and clinics, clinical research organizations, and tobacco product manufacturers through digital submissions, on-site inspections, and structured fee-based processes.

The authority operates an integrated digital regulatory stack centered on IRIMS CLIENT (Integrated Regulatory Information Management System) for processing product registration, licensing, and import/export applications; PVMIS for pharmacovigilance monitoring of adverse drug reactions; VIGIMOBILE and WHO-supported VigiFlow for reporting adverse events following immunization and medicine use; a dedicated e-Learning platform for stakeholder training; and IREMBO PAY for fee collection. Supplementary category-specific portals cover human medicines, veterinary medicines, food products, feed, medical devices, medicated cosmetics and household chemicals, clinical trials, vigilance, premise licensing, and import/export. The organization is governed by documented quality management systems and publishes regulations, guidelines, registered product databases, recalled product lists, and inspection outcomes through its website and active social media channels.

Rwanda FDA's business model is built on transaction-based regulatory fees governed by the Regulations Governing Fees_RwandaFDA_DECEMBER2024, layered on top of Government of Rwanda budget support and donor-funded capacity-building grants such as the €2 million EU Twinning project (May 2023). In December 2024, Rwanda FDA achieved WHO Maturity Level 3 certification, a designation placing it among the more advanced regulatory authorities in Africa, and Rwanda was designated the host country for the African Medicines Agency in June 2023. Strategic partnerships with WHO, the European Union, Expertise France, ANSM, Paul-Ehrlich-Institut, Sciensano, Lithuania's SMCA, ICGEB, and the Ministry of Health underpin a continuing capability upgrade across laboratory services, risk assessment, and vaccine batch release.

Name

Rwanda Food and Drugs Authority

Legal name

Rwanda Food and Drug Authority

Website

https://rwandafda.gov.rw

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

251–500 employees

Short description

Rwanda Food and Drugs Authority is Rwanda's national regulatory authority overseeing medicines, vaccines, food, cosmetics, medical devices, and household chemicals through digital platforms including IRIMS, PVMIS, and e-Learning. It serves manufacturers, distributors, healthcare providers, and CROs across Rwanda.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Food Regulatory Authority

NAICS

Regulation, Licensing, and Inspection of Miscellaneous Commercial Sectors (92615)

SIC

Services-Testing Laboratories (8734)

akta.pro primary industry

Regulatory Compliance, Licensing & Enforcement (Public Health) (HLAJAMAE)

akta.pro secondary industries

Drug Regulators (Human Pharmaceuticals) (HLAJADAA), Medical Device Regulators (HLAJADAC), Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI), Hazardous Chemicals & Toxic Substances Regulators (REACH/TSCA-style) (HLAJAFAF)

Keywords

• Regulatory authority services
• Pharmaceutical product registration
• Food safety regulation
• Medical device licensing
• Pharmacovigilance monitoring

Headquarters

HQ city

Mont Kigali

HQ country

Rwanda

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Regulatory Service Fees: The authority generates revenue through fees for regulatory services including product registration, premise licensing, import/export authorization, and inspection services. Fees are governed by Regulations Governing Fees published by Rwanda FDA.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Rwanda FDA is a statutory regulatory authority that regulates human and veterinary medicines, vaccines and biological products, processed foods, medicated cosmetics, medical devices, household chemical substances, and tobacco products in Rwanda. The authority delivers services including product registration, premise licensing, import/export authorization, GMP/GDP compliance inspection, post-market surveillance, pharmacovigilance, clinical trial oversight, and laboratory quality control testing. These services are delivered through an integrated digital platform ecosystem led by IRIMS CLIENT.

Product overview

Rwanda Food and Drugs Authority is Rwanda's national regulatory body for health products. The authority operates a platform-based digital ecosystem consisting of multiple interconnected regulatory systems. The core infrastructure includes IRIMS CLIENT (Integrated Regulatory Information Management System) for unified regulatory management, PVMIS for pharmacovigilance monitoring, and dedicated e-Learning and customer support platforms. The authority provides regulatory services through specialized systems covering human medicine registration, veterinary medicine registration, food products registration, medical devices registration, medicated cosmetics and household chemicals registration, clinical trial oversight, vigilance, premise licensing, and import/export authorization. These systems collectively enable end-to-end regulatory oversight from product registration and premises licensing through post-market surveillance and adverse event monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

• IRIMS CLIENT Integrated Regulatory Information Management System serving as the central client window for regulatory submissions, product registrations, premise licensing, and compliance management across all regulated product categories. Used by pharmaceutical manufacturers, food processors, cosmetics companies, medical device firms, and importers/exporters operating in Rwanda.
• PVMIS - Pharmacovigilance Monitoring System System for monitoring and tracking adverse events and adverse drug reactions following vaccination and medicine use in Rwanda. Used by healthcare providers, pharmaceutical companies, and the public for reporting safety signals.
• Rwanda FDA e-Learning Platform Online learning platform for training and capacity building in regulatory science, pharmaceutical regulations, food safety, and healthcare compliance. Used by industry professionals and regulatory staff.
• Human Medicine Registration Service Registration service for human medicinal products including regulations, guidelines, application forms, and a public registered products database. Used by pharmaceutical manufacturers seeking market authorization in Rwanda.
• Veterinary Medicine Registration Service Registration service for veterinary medicinal products and biological immunological products including regulations, guidelines, forms, and a registered products database. Used by veterinary pharmaceutical companies.
• Food Products Registration Service Registration service for processed food products with regulations, guidelines, application requirements, and a public registered food products database. Used by food manufacturers and importers seeking market authorization in Rwanda.
• Medical Devices Registration Service Registration service for human and veterinary medical devices and in-vitro diagnostics, providing regulations, guidelines, and product registration processes. Used by medical device manufacturers and traders.
• Medicated Cosmetics and Household Chemicals Registration Service Registration service for medicated cosmetics, antiseptics, disinfectants, household pesticides, cleaning chemicals, and laboratory chemicals including dedicated regulation and guideline portals for each sub-category. Used by cosmetics and chemicals manufacturers and importers.
• Clinical Trial Oversight Service Regulatory oversight service for clinical trials conducted in Rwanda, including authorization, monitoring, and a public clinical trial register. Used by clinical research sponsors, CROs, and investigators.
• Premise Licensing and Inspection Service Premise licensing and inspection service for retail pharmacies, wholesale distributors, and manufacturing facilities, including GMP and GDP compliance verification. Used by pharmaceutical and food businesses operating physical premises in Rwanda.
• Import/Export Authorization Service Online authorization service for import and export of medicines, food products, medical devices, and other regulated products into and out of Rwanda. Used by importers, exporters, and distributors of regulated products.
• Quality Control Laboratory Service Quality control laboratory testing services for drugs and other regulated products to verify safety, quality, and compliance with published standards. Operated under the Laboratory Services Department with a defined drugs testing scope.

Quantifiable outcome

• WHO Maturity Level 3 achieved
• +1 more outcomes

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• ICGEB (International Centre for Genetic Engineering and Biotechnology)coreStrategic or Co-development Partner · 25 July 2023Rwanda FDA signed MoU with ICGEB to enhance training and collaboration. The partnership focuses on capacity building and knowledge sharing in regulatory sciences.
• World Health Organization (WHO)coreStrategic or Co-development PartnerWHO supports Rwanda FDA through benchmarking, capacity building, and regulatory system development. Rwanda FDA achieved WHO Maturity Level 3 under this partnership.
• Expertise FrancecoreImplementation/ SI/ Consulting PartnerFrench technical cooperation agency implementing the EU-funded Twinning project for Rwanda FDA regulatory strengthening.
• ANSM (French National Agency for Medicines and Health Products)coreStrategic or Co-development PartnerPart of EU Twinning project consortium providing expertise in medicines regulation from French regulatory perspective.
• Paul-Ehrlich-Institut (German Federal Institute for Vaccines and Biomedicines)coreStrategic or Co-development PartnerPart of EU Twinning project consortium providing vaccine and biomedicines regulatory expertise.
• Sciensano (Belgium)coreStrategic or Co-development PartnerPart of EU Twinning project consortium providing expertise from Belgian health institute.
• State Medicines Control Agency of LithuaniacoreStrategic or Co-development PartnerPart of EU Twinning project consortium providing Eastern European regulatory perspective.
• Ministry of Health (Rwanda)coreStrategic or Co-development PartnerParent ministry providing policy direction and coordination with national health strategies.
• Management Sciences for Health (MSH)minorStrategic or Co-development PartnerInternational health organization supporting healthcare systems strengthening in Rwanda.
• University of RwandaminorStrategic or Co-development PartnerAcademic partnership for research, training, and capacity building in pharmaceutical sciences.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• South African Health Products Regulatory Authority (SAHPRA): South Africa's national health products regulator covering medicines, devices, and IVDs. Africa's most mature national regulator and the natural continental benchmark Rwanda FDA is converging toward.
• Ghana Food and Drugs Authority: Ghana's multi-vertical regulator for food, drugs, cosmetics, and medical devices — directly comparable in scope to Rwanda FDA, and one of Africa's more advanced WHO-benchmarked authorities.
• Tanzania Medicines and Medical Devices Authority (TMDA): Tanzania's national regulator for medicines, medical devices, and diagnostics — directly comparable scope and East African regional positioning. Already an information-sharing partner of Rwanda FDA per the data.
• National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria: Nigeria's federal regulator covering food, drugs, cosmetics, medical devices, and chemicals — the largest African analogue to Rwanda FDA in terms of multi-vertical regulatory scope.
• Pharmacy and Poisons Board, Kenya: Kenya's national regulator for medicines, pharmacy practice, and poisons — a direct peer with comparable remit over human pharmaceuticals and pharmacy licensing in East Africa.
• National Drug Authority, Uganda: Uganda's national regulator for human and veterinary medicines — directly comparable East African peer with similar mandate over drug registration, licensing, and pharmacovigilance.

Broad incumbents

• Egyptian Drug Authority (EDA): Egypt's national pharmaceutical regulator — a larger, more established African/EMEA-region authority with broader institutional capacity and a WHO ML3-equivalent track record.

Emerging players

• African Medicines Agency (AMA): Continental-level regulatory body hosted by Rwanda — not a direct national peer but the supranational authority Rwanda FDA will increasingly coordinate with and potentially feed workload into.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/RwandaFDA
• YouTubeyoutube.com/@RwandaFDA
• Facebookfacebook.com/RwandaFDA
• LinkedInrw.linkedin.com/company/rwanda-fda

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rwanda Food and Drugs Authority